OptionsHouse

Options Trading News

January 18, 2013  Fri 7:35 AM CT

MS: SEE CHART GET CHAIN FIND STRATEGIES

Profit Comes in Better Than Expected

Morgan Stanley reported fourth-quarter earnings of $0.28 a share, beating the $0.27 average analyst forecast. Revenue missed expectations, but investors are focusing on that profit number, sending MS up by more than 6 percent before the bell on my tradeMONSTER platform.

FDA Approves Migraine Skin Patch

NuPath announced late yesterday that the Food & Drug Administration approved its Zecuity skin patch for the treatment of migraines, making it the first such product on the market. PATH rallies 19 percent on the news.

Research in Motion Keeps Moving

Research in Motion keeps moving! Today, it was upgraded to "buy" from "hold" at Jefferies, which cited the possibility of its Blackberry mail being able to work on iPhones and Android devices. The target price was raised to $19.50 from $13. RIMM is up 7 percent in the premarket.

Capital One Drops on Earnings Miss

Capital One earned just $1.41 a share in the fourth quarter on revenue of $5.62 billion. Analysts had expected $1.58 and $5.71 billion, respectively. Those results have COF down 7 percent in early trading.

Share this article with your friends


Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

Options Academy: Ron's Risk Calculation--A Real Life Example

It is rare that I get a chance to give a real-life, real-time example in my articles that the readers were not only following but were actually involved in at the time the event is happening. Well, that is where we are right now in our QQQ trade from last week. Let's recap the trade itself.

View more education articles »